Skip to main content
. 2022 Jan 12;14(2):368. doi: 10.3390/cancers14020368

Table 3.

Adherence to active surveillance.

Reasons for Discontinuing Active Surveillance n Percentage of Cohort (391 Patients)
Still on active surveillance 183 46.8%
Disease progression 95 24.3%
Convert to watchful waiting 26 6.6%
Patients choice for active treatment 3 0.8%
Lost to follow-up 68 17.4%
Death 16 4.1%
Total 391 100%